Xxxxx Xxxxxxxx Title definition

Xxxxx Xxxxxxxx Title. Director of Technology Address: 00 Xxxxx Xxx, XX XXX 000, Xxxxxxx, XX 00000 Phone: 000-000-0000
Xxxxx Xxxxxxxx Title. Assistant Director of Education Technology Address: 00000 X Xxxxxx Xxxxxxx Vail, AZ 85641 Telephone Number: 0000000000 Email: xxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx Version1r6 Page 19 of 22 Signature: Xxxxxxx Xxxxxxxx (Jun 27, 2023 09:14 PDT) Email: xxxxxxxxxx@xxxxx.xxx Exhibit E Gipper Final Audit Report 2023-06-27 "Exhibit E Gipper" History Document created by Xxxxxxx Xxxxxxxx (xxxxxxxxxx@xxxxx.xxx) 2023-02-01 - 11:11:41 PM GMT Document emailed to Xxxxx Xxxxxxxx (xxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx) for signature 2023-02-01 - 11:13:58 PM GMT Email viewed by Xxxxx Xxxxxxxx (xxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx) 2023-02-02 - 0:31:15 AM GMT Email viewed by Xxxxx Xxxxxxxx (xxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx) 2023-05-13 - 4:15:47 AM GMT Email viewed by Xxxxx Xxxxxxxx (xxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx) 2023-06-26 - 5:36:58 PM GMT Document e-signed by Xxxxx Xxxxxxxx (xxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx) Signature Date: 2023-06-27 - 2:43:33 PM GMT - Time Source: server Document emailed to Xxxxxxx Xxxxxxxx (xxxxxxxxxx@xxxxx.xxx) for signature 2023-06-27 - 2:43:34 PM GMT Email viewed by Xxxxxxx Xxxxxxxx (xxxxxxxxxx@xxxxx.xxx) 2023-06-27 - 2:43:48 PM GMT Document e-signed by Xxxxxxx Xxxxxxxx (xxxxxxxxxx@xxxxx.xxx) Signature Date: 2023-06-27 - 4:14:10 PM GMT - Time Source: server Agreement completed. 2023-06-27 - 4:14:10 PM GMT Created: 2023-02-01 By: Status: Transaction ID: Xxxxxxx Xxxxxxxx (xxxxxxxxxx@xxxxx.xxx) Signed
Xxxxx Xxxxxxxx Title. Director of Technology SCHOOL DISTRICT NAME: Regional School Unit No 71 DESIGNATED REPRESENTATIVE OF LEA:

Examples of Xxxxx Xxxxxxxx Title in a sentence

  • Holder: By: /s/ Xxxxx Xxxxxxxx Name: Xxxxx Xxxxxxxx Title: Manager Name of Holder: ScanTech Security, LLC By: /s/ Xxxxx Xxxxx Name: Xxxxx Xxxxx Title: Managing Member Name of Holder: Seaport Group SIBS, LLC By: /s/ Xxxx Xxxxxxx Name: Xxxx Xxxxxxx Title: Manager Name of Holder: NACS, LLC By: /s/ Xxxxx Xxxxxxxx Name of Holder: Xxxxx Xxxxxxxx By: /s/ W.


More Definitions of Xxxxx Xxxxxxxx Title

Xxxxx Xxxxxxxx Title. Assistant Director of Education Technology Address: 00000 X Xxxxxx Xxxxxxx Vail, AZ 85641 Telephone Number: 000-000-0000 Email: xxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx
Xxxxx Xxxxxxxx Title. Chief Executive Officer Address: 0000 Xxxxx Xxxxxxxx Xxx Xxxxxxxx X Xxxx, Xxxx 00000
Xxxxx Xxxxxxxx Title. Member of the Executive Board By: /s/ Manfxxx Xxxxxx Name: Manfxxx Xxxxxx Title: Member of the Executive Board COMPUTER 2000, INC. By: /s/ Martxx X. Xxxxxxx By: /s/ Richxxx X. Xxxxxxxxx Xxxe: Martxx X. Xxxxxxx Name: Richxxx X. Xxxxxxxxx Xxxle: President Title: Secretary THE LISTEN GROUP PARTNERS LLC
Xxxxx Xxxxxxxx Title. Vice President Date: December 6, 1996 12 EXHIBIT I Dated December 6, 1996 Smitx Xxxxxx Xxxld Funds, Inc. Emerging Market Portfolio European Portfolio Global Government Bond Portfolio International Balanced Portfolio International Equity Portfolio Pacific Portfolio Smitx Xxxxxx Xxxural Resources Fund Inc. Smitx Xxxxxx Xxxome Funds Smitx Xxxxxx Xxxersified Strategic Income Fund Consulting Group Capital Markets Funds (TRAK) International Equity Investments International Fixed Income Investments Emerging Markets Equity Investments The Italy Fund Travelers Series Fund Inc. (Vintage) GT Global Strategic Income Portfolio Smitx Xxxxxx Xxxernational Equity Portfolio Smitx Xxxxxx Xxxific Basin Portfolio Travelers Series Trust (Architect) Lazard International Stock Portfolio Smitx Xxxxxx Xxxies Trust (Symphony) Diversified Strategic Income Fund International Equity Fund 13 Investment Company Rider to Global Custody Agreement Between The Chase Manhattan Bank and Each of the Investment Companies listed on Exhibit l to said Global Custody Agreement effective December 6, 1996 Customer represents that the Assets being placed in Bank's custody are subject to the Investment Company Act of 1940, as amended (the "1940 Act"), as the same may be amended from time to time. Except to the extent that Bank has specifically agreed to comply with a condition of a rule, regulation interpretation promulgated by or under the authority of the Securities and Exchange Commission ("SEC") or the Exemptive Order applicable to accounts of this nature issued to Bank (1940 Act, Release No. 12053, November 20, 1981), as amended, or unless Bank has otherwise specifically agreed, Customer shall be solely responsible to assure that the maintenance of Assets hereunder complies with such rules, regulations, interpretations or exemptive order promulgated by or under the authority of the Securities Exchange Commission. The following modifications are made to the Agreement:
Xxxxx Xxxxxxxx Title. Vorstand Title: CEO We do hereby accept and assume joint and several liability with Rhein Minapharm Biogenetics SAE pursuant to the provisions of Section 9.1 of this Agreement: (Place, Date), ____________ Minapharm Pharmaceuticals S.A.E. By: /s/ Xxxxx Xxxxxxxx Name: Xx. Xxxxx Xxxxxxxx Title: CEO [ * ] The following portion has been omitted pursuant to a Confidential Treatment Request under Rule 24b-2 of the Securities Exchange Act of 1934 and has been filed separately with the Securities and Exchange Commission. XXXXX X XXXXXX XXXX XXXXX XXXXXX (MENA) REGION ALL AFRICAN COUNTRIES PLUS THE FOLLOWING MIDDLE EASTERN COUNTRIES: [ * ] [ * ] The following portion has been omitted pursuant to a Confidential Treatment Request under Rule 24b-2 of the Securities Exchange Act of 1934 and has been filed separately with the Securities and Exchange Commission. ANNEX B LICENSED PRODUCT ELAFIN [ * ]. [ * ] The following portion has been omitted pursuant to a Confidential Treatment Request under Rule 24b-2 of the Securities Exchange Act of 1934 and has been filed separately with the Securities and Exchange Commission. ANNEX C.1 [ * ] The following portion has been omitted pursuant to a Confidential Treatment Request under Rule 24b-2 of the Securities Exchange Act of 1934 and has been filed separately with the Securities and Exchange Commission. ANNEX C.2 PROTEO BIOTECH AG KNOW-HOW PACKAGE FOR PRODUCTION OF R-ELAFIN [ * ] [ * ] The following portion has been omitted pursuant to a Confidential Treatment Request under Rule 24b-2 of the Securities Exchange Act of 1934 and has been filed separately with the Securities and Exchange Commission. ANNEX D ASSISTANCE AND PROCESS TRAINING [ * ] [ * ] The following portion has been omitted pursuant to a Confidential Treatment Request under Rule 24b-2 of the Securities Exchange Act of 1934 and has been filed separately with the Securities and Exchange Commission.

Related to Xxxxx Xxxxxxxx Title